Found: 22
Select item for more details and to access through your institution.
Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 2218, doi. 10.1002/alz.12549
- By:
- Publication type:
- Article
Quantitative proteomics of detergent insoluble tangles derived from Alzheimer's disease brains.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.055040
- By:
- Publication type:
- Article
Neurofilament light chain in psychiatric and neurodegenerative disorders: A 'c‐reactive protein' for the brain?: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041347
- By:
- Publication type:
- Article
Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers.
- Published in:
- Frontiers in Aging Neuroscience, 2014, v. 6, p. 1, doi. 10.3389/fnagi.2014.00248
- By:
- Publication type:
- Article
CSF TOTAL TAU AS A BIOMARKER FOR NEURONAL INJURY IN ALZHEIMER’S DISEASE: ALIGNING RATES OF CSF CHANGE WITH RATES OF HIPPOCAMPAL AND CORTICAL GRAY MATTER ATROPHY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P436, doi. 10.1016/j.jalz.2017.06.432
- By:
- Publication type:
- Article
The correlation between ß-amyloid PET-imaging and cerebrospinal fluid biomarkers is affected by the assay design.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P297, doi. 10.1016/j.jalz.2015.07.409
- By:
- Publication type:
- Article
Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders.
- Published in:
- Acta Neuropsychiatrica, 2024, v. 36, n. 1, p. 17, doi. 10.1017/neu.2023.25
- By:
- Publication type:
- Article
α-Synuclein Levels in Blood Plasma from LRRK2 Mutation Carriers.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0052312
- By:
- Publication type:
- Article
Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains.
- Published in:
- Journal of Neurochemistry, 2023, v. 164, n. 4, p. 529, doi. 10.1111/jnc.15713
- By:
- Publication type:
- Article
Cerebrospinal fluid neurofilament light and cerebral atrophy in younger‐onset dementia and primary psychiatric disorders.
- Published in:
- Internal Medicine Journal, 2023, v. 53, n. 9, p. 1564, doi. 10.1111/imj.15956
- By:
- Publication type:
- Article
"An umbrella made of precious gems": An Examination of Memory and Diasporic Identities in Kerala Jewish Songs and Literature.
- Published in:
- Rupkatha Journal on Interdisciplinary Studies in Humanities, 2020, v. 12, n. 5, p. 1, doi. 10.21659/rupkatha.v12n5.rioc1s32n1
- By:
- Publication type:
- Article
Plant poisoning leads to alpha-synucleinopathy and neuromelanopathy in kangaroos.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-53396-8
- By:
- Publication type:
- Article
Long term follow up of neglected quadriceps palsy treated by hamstring transfer.
- Published in:
- Kerala Journal of Orthopaedics, 2014, v. 27, n. 1, p. 35
- By:
- Publication type:
- Article
Diagnostic performance of CSF biomarkers in a well-characterized Australian cohort of sporadic Creutzfeldt-Jakob disease.
- Published in:
- Frontiers in Neurology, 2023, v. 14, p. 01, doi. 10.3389/fneur.2023.1072952
- By:
- Publication type:
- Article
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2014, v. 6, n. 3, p. 1, doi. 10.1186/alzrt255
- By:
- Publication type:
- Article
Alzheimer's disease biomarker utilization at first referral enhances differential diagnostic precision with simultaneous exclusion of Creutzfeldt‐Jakob disease.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2024, v. 16, n. 1, p. 1, doi. 10.1002/dad2.12548
- By:
- Publication type:
- Article
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
- Published in:
- Molecular Neurodegeneration, 2016, v. 11, p. 1, doi. 10.1186/s13024-016-0072-9
- By:
- Publication type:
- Article
Cerebrospinal fluid neurofilament light chain is elevated in Niemann–Pick type C compared to psychiatric disorders and healthy controls and may be a marker of treatment response.
- Published in:
- 2020
- By:
- Publication type:
- Letter
A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?
- Published in:
- Australian & New Zealand Journal of Psychiatry, 2020, v. 54, n. 1, p. 57, doi. 10.1177/0004867419857811
- By:
- Publication type:
- Article
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease.
- Published in:
- Movement Disorders, 2014, v. 29, n. 8, p. 1019, doi. 10.1002/mds.25772
- By:
- Publication type:
- Article
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias.
- Published in:
- Movement Disorders, 2011, v. 26, n. 8, p. 1428, doi. 10.1002/mds.23670
- By:
- Publication type:
- Article